nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Lymphopenia—Sorafenib—thyroid cancer	0.0351	0.0351	CcSEcCtD
Zanamivir—Dehydration—Vandetanib—thyroid cancer	0.018	0.018	CcSEcCtD
Zanamivir—Influenza like illness—Sorafenib—thyroid cancer	0.0174	0.0174	CcSEcCtD
Zanamivir—Influenza—Vandetanib—thyroid cancer	0.0167	0.0167	CcSEcCtD
Zanamivir—Bronchospasm—Vandetanib—thyroid cancer	0.0164	0.0164	CcSEcCtD
Zanamivir—Bronchitis—Vandetanib—thyroid cancer	0.0161	0.0161	CcSEcCtD
Zanamivir—Neutropenia—Vandetanib—thyroid cancer	0.0156	0.0156	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.0148	0.0148	CcSEcCtD
Zanamivir—Sinusitis—Vandetanib—thyroid cancer	0.014	0.014	CcSEcCtD
Zanamivir—Haemoglobin—Vandetanib—thyroid cancer	0.0134	0.0134	CcSEcCtD
Zanamivir—Haemorrhage—Vandetanib—thyroid cancer	0.0134	0.0134	CcSEcCtD
Zanamivir—Lymphopenia—Epirubicin—thyroid cancer	0.013	0.013	CcSEcCtD
Zanamivir—Erythema multiforme—Vandetanib—thyroid cancer	0.0126	0.0126	CcSEcCtD
Zanamivir—Dehydration—Sorafenib—thyroid cancer	0.0121	0.0121	CcSEcCtD
Zanamivir—Lymphopenia—Doxorubicin—thyroid cancer	0.012	0.012	CcSEcCtD
Zanamivir—Arrhythmia—Vandetanib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.0117	0.0117	CcSEcCtD
Zanamivir—Neutropenia—Sorafenib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Zanamivir—Loss of consciousness—Vandetanib—thyroid cancer	0.0102	0.0102	CcSEcCtD
Zanamivir—Cough—Vandetanib—thyroid cancer	0.0102	0.0102	CcSEcCtD
Zanamivir—Convulsion—Vandetanib—thyroid cancer	0.0101	0.0101	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00995	0.00995	CcSEcCtD
Zanamivir—Arthralgia—Vandetanib—thyroid cancer	0.0099	0.0099	CcSEcCtD
Zanamivir—Anxiety—Vandetanib—thyroid cancer	0.00987	0.00987	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00983	0.00983	CcSEcCtD
Zanamivir—Infection—Vandetanib—thyroid cancer	0.00943	0.00943	CcSEcCtD
Zanamivir—Lung disorder—Epirubicin—thyroid cancer	0.00937	0.00937	CcSEcCtD
Zanamivir—Skin disorder—Vandetanib—thyroid cancer	0.00922	0.00922	CcSEcCtD
Zanamivir—Haemoglobin—Sorafenib—thyroid cancer	0.00906	0.00906	CcSEcCtD
Zanamivir—Haemorrhage—Sorafenib—thyroid cancer	0.00901	0.00901	CcSEcCtD
Zanamivir—Lung disorder—Doxorubicin—thyroid cancer	0.00867	0.00867	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00865	0.00865	CcSEcCtD
Zanamivir—Erythema multiforme—Sorafenib—thyroid cancer	0.00852	0.00852	CcSEcCtD
Zanamivir—Dyspnoea—Vandetanib—thyroid cancer	0.00846	0.00846	CcSEcCtD
Zanamivir—Decreased appetite—Vandetanib—thyroid cancer	0.00825	0.00825	CcSEcCtD
Zanamivir—Fatigue—Vandetanib—thyroid cancer	0.00818	0.00818	CcSEcCtD
Zanamivir—Pain—Vandetanib—thyroid cancer	0.00812	0.00812	CcSEcCtD
Zanamivir—Arrhythmia—Sorafenib—thyroid cancer	0.00805	0.00805	CcSEcCtD
Zanamivir—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00776	0.00776	CcSEcCtD
Zanamivir—Delirium—Epirubicin—thyroid cancer	0.00771	0.00771	CcSEcCtD
Zanamivir—Abdominal pain—Vandetanib—thyroid cancer	0.0075	0.0075	CcSEcCtD
Zanamivir—Body temperature increased—Vandetanib—thyroid cancer	0.0075	0.0075	CcSEcCtD
Zanamivir—Delirium—Doxorubicin—thyroid cancer	0.00714	0.00714	CcSEcCtD
Zanamivir—Syncope—Sorafenib—thyroid cancer	0.00704	0.00704	CcSEcCtD
Zanamivir—Loss of consciousness—Sorafenib—thyroid cancer	0.0069	0.0069	CcSEcCtD
Zanamivir—Cough—Sorafenib—thyroid cancer	0.00685	0.00685	CcSEcCtD
Zanamivir—Asthenia—Vandetanib—thyroid cancer	0.00681	0.00681	CcSEcCtD
Zanamivir—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00671	0.00671	CcSEcCtD
Zanamivir—Arthralgia—Sorafenib—thyroid cancer	0.00668	0.00668	CcSEcCtD
Zanamivir—Myalgia—Sorafenib—thyroid cancer	0.00668	0.00668	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00663	0.00663	CcSEcCtD
Zanamivir—Diarrhoea—Vandetanib—thyroid cancer	0.0065	0.0065	CcSEcCtD
Zanamivir—Influenza like illness—Epirubicin—thyroid cancer	0.00644	0.00644	CcSEcCtD
Zanamivir—Anaphylactic shock—Sorafenib—thyroid cancer	0.0064	0.0064	CcSEcCtD
Zanamivir—Infection—Sorafenib—thyroid cancer	0.00636	0.00636	CcSEcCtD
Zanamivir—Shock—Sorafenib—thyroid cancer	0.0063	0.0063	CcSEcCtD
Zanamivir—Dizziness—Vandetanib—thyroid cancer	0.00628	0.00628	CcSEcCtD
Zanamivir—Skin disorder—Sorafenib—thyroid cancer	0.00622	0.00622	CcSEcCtD
Zanamivir—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00621	0.00621	CcSEcCtD
Zanamivir—Anorexia—Sorafenib—thyroid cancer	0.0061	0.0061	CcSEcCtD
Zanamivir—Vomiting—Vandetanib—thyroid cancer	0.00604	0.00604	CcSEcCtD
Zanamivir—Rash—Vandetanib—thyroid cancer	0.00599	0.00599	CcSEcCtD
Zanamivir—Dermatitis—Vandetanib—thyroid cancer	0.00598	0.00598	CcSEcCtD
Zanamivir—Influenza like illness—Doxorubicin—thyroid cancer	0.00596	0.00596	CcSEcCtD
Zanamivir—Headache—Vandetanib—thyroid cancer	0.00595	0.00595	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00583	0.00583	CcSEcCtD
Zanamivir—Dyspnoea—Sorafenib—thyroid cancer	0.00571	0.00571	CcSEcCtD
Zanamivir—Nausea—Vandetanib—thyroid cancer	0.00564	0.00564	CcSEcCtD
Zanamivir—Decreased appetite—Sorafenib—thyroid cancer	0.00557	0.00557	CcSEcCtD
Zanamivir—Fatigue—Sorafenib—thyroid cancer	0.00552	0.00552	CcSEcCtD
Zanamivir—Pain—Sorafenib—thyroid cancer	0.00548	0.00548	CcSEcCtD
Zanamivir—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00524	0.00524	CcSEcCtD
Zanamivir—Increased appetite—Epirubicin—thyroid cancer	0.00513	0.00513	CcSEcCtD
Zanamivir—Urticaria—Sorafenib—thyroid cancer	0.00509	0.00509	CcSEcCtD
Zanamivir—Abdominal pain—Sorafenib—thyroid cancer	0.00506	0.00506	CcSEcCtD
Zanamivir—Body temperature increased—Sorafenib—thyroid cancer	0.00506	0.00506	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00498	0.00498	CcSEcCtD
Zanamivir—Increased appetite—Doxorubicin—thyroid cancer	0.00474	0.00474	CcSEcCtD
Zanamivir—Hypersensitivity—Sorafenib—thyroid cancer	0.00472	0.00472	CcSEcCtD
Zanamivir—Face oedema—Epirubicin—thyroid cancer	0.00465	0.00465	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.0046	0.0046	CcSEcCtD
Zanamivir—Asthenia—Sorafenib—thyroid cancer	0.00459	0.00459	CcSEcCtD
Zanamivir—Dehydration—Epirubicin—thyroid cancer	0.00448	0.00448	CcSEcCtD
Zanamivir—Diarrhoea—Sorafenib—thyroid cancer	0.00438	0.00438	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00434	0.00434	CcSEcCtD
Zanamivir—Face oedema—Doxorubicin—thyroid cancer	0.0043	0.0043	CcSEcCtD
Zanamivir—Dizziness—Sorafenib—thyroid cancer	0.00423	0.00423	CcSEcCtD
Zanamivir—Asthma—Epirubicin—thyroid cancer	0.00416	0.00416	CcSEcCtD
Zanamivir—Influenza—Epirubicin—thyroid cancer	0.00416	0.00416	CcSEcCtD
Zanamivir—Dehydration—Doxorubicin—thyroid cancer	0.00414	0.00414	CcSEcCtD
Zanamivir—Vomiting—Sorafenib—thyroid cancer	0.00407	0.00407	CcSEcCtD
Zanamivir—Rash—Sorafenib—thyroid cancer	0.00404	0.00404	CcSEcCtD
Zanamivir—Dermatitis—Sorafenib—thyroid cancer	0.00403	0.00403	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00401	0.00401	CcSEcCtD
Zanamivir—Headache—Sorafenib—thyroid cancer	0.00401	0.00401	CcSEcCtD
Zanamivir—Bronchitis—Epirubicin—thyroid cancer	0.004	0.004	CcSEcCtD
Zanamivir—Neutropenia—Epirubicin—thyroid cancer	0.00389	0.00389	CcSEcCtD
Zanamivir—Asthma—Doxorubicin—thyroid cancer	0.00385	0.00385	CcSEcCtD
Zanamivir—Influenza—Doxorubicin—thyroid cancer	0.00385	0.00385	CcSEcCtD
Zanamivir—Nausea—Sorafenib—thyroid cancer	0.0038	0.0038	CcSEcCtD
Zanamivir—Bronchitis—Doxorubicin—thyroid cancer	0.0037	0.0037	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00368	0.00368	CcSEcCtD
Zanamivir—Neutropenia—Doxorubicin—thyroid cancer	0.0036	0.0036	CcSEcCtD
Zanamivir—Sinusitis—Epirubicin—thyroid cancer	0.00348	0.00348	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.0034	0.0034	CcSEcCtD
Zanamivir—Haemoglobin—Epirubicin—thyroid cancer	0.00335	0.00335	CcSEcCtD
Zanamivir—Haemorrhage—Epirubicin—thyroid cancer	0.00333	0.00333	CcSEcCtD
Zanamivir—Sinusitis—Doxorubicin—thyroid cancer	0.00322	0.00322	CcSEcCtD
Zanamivir—Erythema multiforme—Epirubicin—thyroid cancer	0.00315	0.00315	CcSEcCtD
Zanamivir—Haemoglobin—Doxorubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Zanamivir—Haemorrhage—Doxorubicin—thyroid cancer	0.00308	0.00308	CcSEcCtD
Zanamivir—Chills—Epirubicin—thyroid cancer	0.00299	0.00299	CcSEcCtD
Zanamivir—Arrhythmia—Epirubicin—thyroid cancer	0.00298	0.00298	CcSEcCtD
Zanamivir—Erythema multiforme—Doxorubicin—thyroid cancer	0.00291	0.00291	CcSEcCtD
Zanamivir—Chills—Doxorubicin—thyroid cancer	0.00277	0.00277	CcSEcCtD
Zanamivir—Arrhythmia—Doxorubicin—thyroid cancer	0.00275	0.00275	CcSEcCtD
Zanamivir—Ill-defined disorder—Epirubicin—thyroid cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Agitation—Epirubicin—thyroid cancer	0.00266	0.00266	CcSEcCtD
Zanamivir—Malaise—Epirubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Zanamivir—Syncope—Epirubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Zanamivir—Loss of consciousness—Epirubicin—thyroid cancer	0.00255	0.00255	CcSEcCtD
Zanamivir—Cough—Epirubicin—thyroid cancer	0.00253	0.00253	CcSEcCtD
Zanamivir—Convulsion—Epirubicin—thyroid cancer	0.00251	0.00251	CcSEcCtD
Zanamivir—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00249	0.00249	CcSEcCtD
Zanamivir—Myalgia—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Zanamivir—Arthralgia—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Zanamivir—Agitation—Doxorubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Zanamivir—Anxiety—Epirubicin—thyroid cancer	0.00246	0.00246	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00245	0.00245	CcSEcCtD
Zanamivir—Discomfort—Epirubicin—thyroid cancer	0.00244	0.00244	CcSEcCtD
Zanamivir—Malaise—Doxorubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Zanamivir—Syncope—Doxorubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Zanamivir—Confusional state—Epirubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Zanamivir—Anaphylactic shock—Epirubicin—thyroid cancer	0.00237	0.00237	CcSEcCtD
Zanamivir—Loss of consciousness—Doxorubicin—thyroid cancer	0.00236	0.00236	CcSEcCtD
Zanamivir—Infection—Epirubicin—thyroid cancer	0.00235	0.00235	CcSEcCtD
Zanamivir—Cough—Doxorubicin—thyroid cancer	0.00234	0.00234	CcSEcCtD
Zanamivir—Shock—Epirubicin—thyroid cancer	0.00233	0.00233	CcSEcCtD
Zanamivir—Convulsion—Doxorubicin—thyroid cancer	0.00232	0.00232	CcSEcCtD
Zanamivir—Skin disorder—Epirubicin—thyroid cancer	0.0023	0.0023	CcSEcCtD
Zanamivir—Myalgia—Doxorubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Zanamivir—Arthralgia—Doxorubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Zanamivir—Anxiety—Doxorubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Discomfort—Doxorubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Zanamivir—Anorexia—Epirubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Zanamivir—Confusional state—Doxorubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Zanamivir—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00219	0.00219	CcSEcCtD
Zanamivir—Infection—Doxorubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Shock—Doxorubicin—thyroid cancer	0.00215	0.00215	CcSEcCtD
Zanamivir—Skin disorder—Doxorubicin—thyroid cancer	0.00213	0.00213	CcSEcCtD
Zanamivir—Dyspnoea—Epirubicin—thyroid cancer	0.00211	0.00211	CcSEcCtD
Zanamivir—Anorexia—Doxorubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Zanamivir—Decreased appetite—Epirubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Zanamivir—Fatigue—Epirubicin—thyroid cancer	0.00204	0.00204	CcSEcCtD
Zanamivir—Pain—Epirubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Zanamivir—Dyspnoea—Doxorubicin—thyroid cancer	0.00195	0.00195	CcSEcCtD
Zanamivir—Feeling abnormal—Epirubicin—thyroid cancer	0.00195	0.00195	CcSEcCtD
Zanamivir—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Zanamivir—Decreased appetite—Doxorubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Zanamivir—Fatigue—Doxorubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Zanamivir—Urticaria—Epirubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Zanamivir—Pain—Doxorubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Zanamivir—Abdominal pain—Epirubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Zanamivir—Body temperature increased—Epirubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Zanamivir—Feeling abnormal—Doxorubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Zanamivir—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Zanamivir—Hypersensitivity—Epirubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Zanamivir—Urticaria—Doxorubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Zanamivir—Abdominal pain—Doxorubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Zanamivir—Body temperature increased—Doxorubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Zanamivir—Asthenia—Epirubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Zanamivir—Diarrhoea—Epirubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Zanamivir—Hypersensitivity—Doxorubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Zanamivir—Asthenia—Doxorubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Zanamivir—Dizziness—Epirubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Zanamivir—Vomiting—Epirubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Zanamivir—Diarrhoea—Doxorubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Zanamivir—Rash—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Zanamivir—Dermatitis—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Zanamivir—Headache—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Zanamivir—Dizziness—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Zanamivir—Nausea—Epirubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Zanamivir—Vomiting—Doxorubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Zanamivir—Rash—Doxorubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Zanamivir—Dermatitis—Doxorubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Zanamivir—Headache—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Zanamivir—Nausea—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
